ArticlemedRxiv : the preprint server for health sciences2020
Janus Kinase-Inhibitor and Type I Interferon Ability to Produce Favorable Clinical Outcomes in COVID-19 Patients: A Systematic Review and Meta-Analysis.
Lucas Walz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.